ReleaseWire Connect

Gene Therapy Musculoskeletal Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Report Musculoskeletal provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Respiratory Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape report provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Respiratory Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Oncology Report provides the target gene name, localization of gene, molecular function of target with descriptive mechanism of action. Using the propriety Publisher Competitive Matrix models, the report also provides the first in class market analytics providing predictive analysis of early market winners of the clinical therapies and pre-clinical therapies in a demographic presentation view.

A complete ranking and review of Japan's top 300 retailers in FY2013, including sales, profit & stores Japan's Top 300 Retailers is a concise summary of the key trends and shifts in Japanese retailing in FY2013 combined with a complete ranking of the top 300 retailers.

Japan is one of the top 3 consumer markets in the world, yet many consumer goods companies steer clear because it seems so forbidding.

Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets, approaches and biology are discovered. Improved health care, nutrition and preventive medicine in the last few decades have all helped in increasing life expectancy WW. However, this has not translated in any reduction in the incidences or prevalence of chronic or critical illnesses! On the contrary, the incidence of chronic diseases like diabetes, obesity, arthritis etc. as well as cancer and the maladies associated with aging (dementia, Alzheimer's etc.) are on the rise!. Consequently the pharma industry continues to grow and is projected to achieve sales in excess of the trillion dollar mark by 2020. By the next decade, one field which is poised to bring a paradigm change in the way diseases are treated is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic has reached a critical mass, warranting a close watch by those interested in keeping pace with the development of new medicines.

While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies is dependent on the identification of important genomic alterations in cancerous cells that allow for the tumor's sub classification. Over the past decade, Proteasome inhibitor and the immunomodulatory drugs have become the cornerstone of treatment for pts with Multiple Myeloma (MM) resulting in improved survival. However, eventually all pts relapse and use of modern diagnosis will enable risk stratification to help distinguish pts along the spectrum of the condition. This can aid in the selection of new treatment options for Relapsed/ Refractory Multiple Myeloma (RRMM) to further improve survival and quality of life of each patient. Two new drugs have successfully fulfilled this need – POMALYST/ IMNOVID (pomalidomide – POM, Celgene, approved) and Kyprolis (carfilzomib-CFZ, Amgen/ Ono Pharma – JP, approved).

Connected Home is an extension of home automation and operators in conjunction with the Internet of Things (IoT) wherein devices inside the home are connected to each other via the Internet and/or via a short-range wireless mesh network and are typically operated using remote access device such as smartphone, tablet or any other mobile computing unit. There is significant growth potential in this market as market leaders such as Google, Netflix, and others have laid the foundation for many other ecosystem competitors to expand beyond home entertainment into many other areas.

Debt purchase and debt collection are increasingly important UK industries with their services being used ever more widely. In the financial sector, their use has helped banks not only to improve recoveries but also to meet capital ratio requirements. The services are also increasingly being used in other areas where there are significant consumer debts, such as telecoms and utilities, as well as in areas of the public sector.

UK parcels market report shows that it continues to pick up speed after the recession with both higher margins and a more positive outlook for market growth than this time last year. The market is now over £8bn in size with the main driver of parcel volumes, and service innovations, continuing to be the growth of home shopping.